Robert Lambert
Adult Medicine · Yoakum, TXNPI 1699877720
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $668 and has fallen 94.3% since, to $38 in 2024.
Across 160 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$469
- Merck$270
- Johnson & Johnson$212
- AbbVie$163
- Lilly USA, LLC$157
- Amgen$147
- plus $940 from 14 others
What the payments were for
- Food & beverage$2,358100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $469 |
| Merck | 18 | $270 |
| Johnson & Johnson | 13 | $212 |
| AbbVie(2 entities) | 10 | $163 |
| Lilly USA, LLC | 10 | $157 |
| Amgen | 9 | $147 |
| Nestle Healthcare Nutrition Inc. | 9 | $132 |
| Otsuka America Pharmaceutical, Inc. | 6 | $111 |
| Astellas Pharma US Inc | 8 | $105 |
| Philips North America LLC | 7 | $95 |
| AstraZeneca | 6 | $95 |
| Kowa Pharmaceuticals America, Inc. | 4 | $79 |
| Pfizer | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Sanofi Pasteur Inc. | 3 | $51 |
| Exact Sciences | 3 | $49 |
| Paratek Pharmaceuticals, Inc. | 3 | $46 |
| Novartis | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| GSK | 1 | $13 |
How this compares
$2,358 in reported general payments places this provider in the 75th percentile of 98 adult medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 41 | $21,052 |
| JanuviaSitagliptin Phosphate | 11 | $4,552 |
| XareltoRivaroxaban | 11 | $3,121 |
| Dexlansoprazole DrDexlansoprazole | 11 | $2,313 |
| Potassium Chloride | 60 | $925 |
| Atorvastatin Calcium | 110 | $908 |
| FenofibrateFenofibrate Nanocrystallized | 28 | $517 |
| Tamsulosin Hcl | 45 | $508 |
| Gabapentin | 32 | $488 |
| Metoprolol Succinate | 28 | $468 |
| Losartan Potassium | 47 | $406 |
| Amlodipine Besylate | 73 | $325 |
| Spironolactone | 32 | $245 |
| Memantine Hcl | 29 | $244 |
| Omeprazole | 17 | $242 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $63 | $21,05241 claims |
| MerckJanuvia | $270 | $4,55211 claims |
| Johnson & JohnsonXarelto | $212 | $3,12111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 98 adult medicine providers in Texas.
Other adult medicine in Yoakum
- Deborah HornBellaire$723K
- Thomas MartensPflugerville$87K
- Sakuntalai SrinanthakumarBeaumont$48K
- Francisco Vera AdamesSpring$11K
- Latisha RoweHouston$11K
- Hong XiaoCarrollton$10K
- Mark NovasSheppard Afb$9K
- Daisy ArceWeslaco$9K
- Jeffory ThomasTexarkana$8K
- Manuel SanchezMcAllen$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.